Research Articles | Page 6 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Monitoring and treatment of MDS in genetically susceptible persons Dec 2019 Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Lowering the boom on lower-risk myelodysplastic syndromes Dec 2019 Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome Dec 2019 Hematology. American Society of Hematology. Education Program Aplastic Anemia
Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study Dec 2019 JAMA Oncology Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis Dec 2019 Leukemia Myelodysplastic Syndromes (MDS)
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party Dec 2019 Bone Marrow Transplantation Aplastic Anemia
Clonal dynamics of aplastic anemia/paroxysmal nocturnal hemoglobinuria Dec 2019 Leukemia & Lymphoma Aplastic Anemia
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study Jan 2020 Journal of clinical oncology: official journal of the American Society Clinical Oncology Myelodysplastic Syndromes (MDS)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Jan 2020 The New England Journal of Medicine Myelodysplastic Syndromes (MDS)
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria Jan 2020 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)